Patent · US Active

HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders

US9827302B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

GENTICEL · FR

Inventors

Yolande Misseri · Balma, FR
Philippe Bridonneau · Boulder, US
Anne Goubier · Hertford, GB

Key dates

Filing date	Jul 23, 2013
Grant date	Nov 28, 2017
Priority date	—
Expiry date	Jul 23, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y406/01001
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a chimeric protein comprising or consisting of, from N-terminal to C-terminal, (a) a N-terminal part of a Bordetella CyaA protein (b) a heterologous polypeptide comprising antigens originating from different HPVs, and (c) a C-terminal part of a Bordetella CyaA protein. The invention also relates to a polynucleotide encoding this chimeric protein. A composition comprising at least one chimeric protein(s) of the invention and the prophylactic and/or therapeutic uses of said composition are also part of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.